Skip to main content

stock

MBIO · MUSTANG BIO, INC.

What MUSTANG BIO, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live MBIO price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on MBIO.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
Not reported.

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-40.2%
ROA
-19.4%

Health

Current ratio
—
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$1.17M-$1.07M
10-Q filed 2026-08-05
2026-03-31——Gross profit: unreported by this company.-$1.06M-$955,000
10-Q filed 2026-05-05
2025-12-31——Gross profit: unreported by this company.-$670,000-$538,000
10-K filed 2026-03-19
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30——Gross profit: unreported by this company.-$624,000-$468,000
10-Q filed 2025-11-07
2025-06-30——Gross profit: unreported by this company.-$885,000-$762,000
10-Q filed 2026-08-05
2025-03-31——Gross profit: unreported by this company.-$253,000-$153,000
10-Q filed 2026-05-05
2024-12-31——Gross profit: unreported by this company.-$1.02M-$952,000
10-K filed 2026-03-19
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30——Gross profit: unreported by this company.-$1.46M-$1.41M
10-Q filed 2025-11-07
Assets
$15.61M
Equity
$7.54M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$2.43M-$1.92M—
2024-12-31—-$16.25M-$15.75M-$11.41M
2023-12-31—-$49.26M-$51.60M-$49.54M
2022-12-31—-$76.16M-$77.53M-$67.78M
2021-12-31—-$66.72M-$66.37M-$57.65M
2020-12-31—-$56.81M-$60.02M-$39.24M
2019-12-31—-$45.88M-$46.39M-$35.93M
2018-12-31—-$31.22M-$30.66M-$26.11M
2017-12-31—-$31.79M-$31.29M-$13.37M
2016-12-31—-$11.36M-$12.65M—

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

News

Stories that named MBIO, and the market events around them.

Sign in to see this

Board

The MBIO board could not be loaded.

Retry the MBIO board

nakagai

Signals on MBIO come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the MBIO board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

MUSTANG BIO, INC. (MBIO): SEC filings, financials and insider trades · Nakagai